211 related articles for article (PubMed ID: 9362351)
1. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.
Mytilinaiou MG; Meyer W; Scheper T; Rigopoulou EI; Probst C; Koutsoumpas AL; Abeles D; Burroughs AK; Komorowski L; Vergani D; Bogdanos DP
Clin Chim Acta; 2012 Aug; 413(15-16):1211-6. PubMed ID: 22503841
[TBL] [Abstract][Full Text] [Related]
4. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
Granito A; Yang WH; Muratori L; Lim MJ; Nakajima A; Ferri S; Pappas G; Quarneti C; Bianchi FB; Bloch DB; Muratori P
Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
[TBL] [Abstract][Full Text] [Related]
5. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against "nuclear dots" in primary biliary cirrhosis.
Szostecki C; Guldner HH; Will H
Semin Liver Dis; 1997 Feb; 17(1):71-8. PubMed ID: 9089912
[TBL] [Abstract][Full Text] [Related]
7. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
Janka C; Selmi C; Gershwin ME; Will H; Sternsdorf T
Hepatology; 2005 Mar; 41(3):609-16. PubMed ID: 15726652
[TBL] [Abstract][Full Text] [Related]
8. Is prevalence of PBC underestimated in patients with systemic sclerosis?
Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibodies in primary biliary cirrhosis.
Invernizzi P; Selmi C; Ranftler C; Podda M; Wesierska-Gadek J
Semin Liver Dis; 2005 Aug; 25(3):298-310. PubMed ID: 16143945
[TBL] [Abstract][Full Text] [Related]
10. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR.
Lin F; Noyer CM; Ye Q; Courvalin JC; Worman HJ
Hepatology; 1996 Jan; 23(1):57-61. PubMed ID: 8550049
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution.
Szostecki C; Will H; Netter HJ; Guldner HH
Scand J Immunol; 1992 Oct; 36(4):555-64. PubMed ID: 1384113
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis.
Szostecki C; Guldner HH; Netter HJ; Will H
J Immunol; 1990 Dec; 145(12):4338-47. PubMed ID: 2258622
[TBL] [Abstract][Full Text] [Related]
14. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two ELISA assays for anti-Sp100 determination.
Manuel Lucena J; Montes Cano M; Luis Caro J; Respaldiza N; Alvarez A; Sánchez-Román J; Núñez-Roldán A; Wichmann I
Ann N Y Acad Sci; 2007 Aug; 1109():203-11. PubMed ID: 17785307
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of patients with primary biliary cirrhosis and anti-SP100 autoantibody positivity].
Tang YM; Bao WM; You LY; Jiang HJ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):359-62. PubMed ID: 24025137
[TBL] [Abstract][Full Text] [Related]
17. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.
Muratori P; Muratori L; Ferrari R; Cassani F; Bianchi G; Lenzi M; Rodrigo L; Linares A; Fuentes D; Bianchi FB
Am J Gastroenterol; 2003 Feb; 98(2):431-7. PubMed ID: 12591064
[TBL] [Abstract][Full Text] [Related]
18. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis.
Sternsdorf T; Guldner HH; Szostecki C; Grötzinger T; Will H
Scand J Immunol; 1995 Aug; 42(2):257-68. PubMed ID: 7631159
[TBL] [Abstract][Full Text] [Related]
19. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
20. Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence.
Bauer A; Habior A; Kraszewska E
J Immunoassay Immunochem; 2013; 34(4):346-55. PubMed ID: 23859785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]